EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Up 295.3% in April

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a large increase in short interest in April. As of April 30th, there was short interest totaling 20,151 shares, an increase of 295.3% from the April 15th total of 5,098 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 301,668 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

A number of analysts have commented on ESLOY shares. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a report on Tuesday. They issued a “hold” rating for the company. Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Finally, HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, EssilorLuxottica currently has an average rating of “Buy”.

EssilorLuxottica Price Performance

Shares of ESLOY traded up $2.15 during trading hours on Wednesday, hitting $99.72. The stock had a trading volume of 26,876 shares, compared to its average volume of 118,723. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99. EssilorLuxottica has a 12 month low of $96.56 and a 12 month high of $186.81. The stock has a fifty day moving average price of $114.63 and a 200 day moving average price of $146.97.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.